Based on these metrics and many more, GILD holds a Value grade of A, while ALNY has a Value grade of D. Both GILD and ALNY are impressive stocks with solid earnings outlooks, but based on these ...
Mark S. King’s January 10 blog post on his award-winning "My Fabulous Disease" site made me aware of a new, and troubling, ...
In a report released on January 21, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research ...
In recent years, the investment landscape has seen a significant shift towards socially responsible investing strategies.
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD – Research Report) and ...
The Global Specialty Pharmaceutical market is experiencing significant growth due to several key market drivers. The increasing prevalence of chronic diseases US, NY, UNITED STATES, January 21 ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of ...
UNAIDS urges speed and compassion urging pharmaceutical companies to enable access to new, life-saving medicines ...
Last Friday saw the USA’s Center for Medicare and Medicaid Services (CMS) announce the selection of 15 new drugs covered ...